Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients

NCT02741323 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

97

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Kidney Diseases

Interventions

DRUG: Maraviroc
DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)